Turkish Adaptation, Reliability, and Validity Study of the Vaccine Acceptance Instrument

Creative Commons License

Kömürlüoğlu A., Akaydın Gültürk E., Yalçın S. S.

Vaccines, cilt.12, sa.5, 2024 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 12 Sayı: 5
  • Basım Tarihi: 2024
  • Doi Numarası: 10.3390/vaccines12050480
  • Dergi Adı: Vaccines
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, Directory of Open Access Journals
  • Anahtar Kelimeler: reliability, scale validation, vaccine, vaccine acceptance, vaccine hesitancy
  • Sivas Cumhuriyet Üniversitesi Adresli: Evet

Özet

This research study aimed to assess the reliability and validity of the Turkish version of the Vaccine Acceptance Instrument (VAI). The VAI is a 20-item Likert-type scale, with responses ranging across seven points. A systematic approach was followed to translate the scale into Turkish, involving translation, expert panel evaluation, back-translation, and pilot testing. The Vaccine Acceptance Instrument and a sociodemographic data form were used for data collection. The reliability of the scale was tested by test–retest analysis, and its internal reliability was examined by Cronbach’s alpha test. The factor structure was examined using Exploratory Factor Analysis (EFA). Confirmatory Factor Analysis (CFA) was employed to assess the scale’s fit. Overall, 229 participants were included in the study. In test–retest reliability analysis, the intraclass correlation coefficient of the scale was 0.992 (95% CI: 0.987–0.996). The Cronbach’s alpha value of the scale was 0.824. A four-factor structure was determined. The model had an acceptable fit [χ2/df = 380.04/164 (2,317) p < 0.001, CFI = 0.91, GFI = 0.90, AGFI = 0.906, NFI = 0.90, RMSEA = 0.076]. The mean total VAI score was 112.71 ± 17.02. The low education level of the mother, being a housewife, and parents not having the COVID-19 vaccine were statistically significantly associated with a low scale score and low vaccine acceptance (p < 0.05). The Turkish adaptation of the VAI demonstrated satisfactory levels of validity and reliability following rigorous testing.